Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Obesity

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...

Overview of Lipid Metabolism

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

Regulation of Food Intake

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Oestradiol and leptin have separate but additive anorexigenic effects and differentially target fat mass in rats.

Journal of neuroendocrinology·2018

Same author

Limiting feeding to the active phase reduces blood pressure without the necessity of caloric reduction or fat mass loss.

American journal of physiology. Regulatory, integrative and comparative physiology·2018

Same author

ACE2 activator diminazene aceturate reduces adiposity but preserves lean mass in young and old rats.

Experimental gerontology·2018

Same author

Activation of the central melanocortin system in rats persistently reduces body and fat mass independently of caloric reduction.

Canadian journal of physiology and pharmacology·2017

Same author

iBAT sympathetic innervation is not required for body weight loss induced by central leptin delivery.

American journal of physiology. Endocrinology and metabolism·2017

Same author

Effect of High-Salt Diet on Age-Related High Blood Pressure and Hypothalamic Redox Signaling.

Pharmacology·2017

Search research articles

Related Experiment Video

Updated: Jul 15, 2026

Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing

Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing

Published on: October 25, 2019

Elevated leptin: consequence or cause of obesity?

Philip J Scarpace¹, Yi Zhang

¹Department of Pharmacology and Therapeutics, University of Florida, Gainesville, Florida 32610, USA. scarpace@ufl.edu

Frontiers in Bioscience : a Journal and Virtual Library

|May 9, 2007

Summary

High leptin levels may cause obesity by inducing leptin resistance, not just result from it. This resistance impairs the body's response to leptin, promoting further weight gain.

More Related Videos

Characterization of Adipocyte-Derived Extracellular Vesicle Secretion Using a CD63-GFP Reporter Mouse Model In Vivo and In Vitro

Characterization of Adipocyte-Derived Extracellular Vesicle Secretion Using a CD63-GFP Reporter Mouse Model In Vivo and In Vitro

Published on: December 5, 2025

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

Related Experiment Videos

Last Updated: Jul 15, 2026

Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing

Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing

Published on: October 25, 2019

Characterization of Adipocyte-Derived Extracellular Vesicle Secretion Using a CD63-GFP Reporter Mouse Model In Vivo and In Vitro

Characterization of Adipocyte-Derived Extracellular Vesicle Secretion Using a CD63-GFP Reporter Mouse Model In Vivo and In Vitro

Published on: December 5, 2025

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

Area of Science:

Neuroendocrinology
Obesity Research
Hormone Signaling

Background:

Leptin, a hormone from fat cells, regulates satiety primarily in the hypothalamus.
Obesity is often associated with leptin resistance, where the body doesn't respond well to leptin.
Current understanding generally views rising leptin levels as a consequence, not a cause, of obesity and resistance.

Purpose of the Study:

To investigate the potential causative role of elevated central leptin in the development of leptin resistance and obesity.
To explore whether chronic central leptin overexpression contributes to obesity phenotypes.

Main Methods:

Inducing chronic overexpression of central leptin in animal models.
Administering a leptin antagonist to block leptin receptors.
Assessing changes in leptin receptors, signaling pathways, and responsiveness to leptin.
Evaluating susceptibility to diet-induced obesity.

Main Results:

Chronic central leptin overexpression led to leptin resistance, characterized by reduced leptin receptors and impaired signaling.
Animals with leptin overexpression showed increased susceptibility to diet-induced obesity.
Blocking leptin receptors with an antagonist also exacerbated diet-induced obesity.

Conclusions:

Elevated central leptin may play a causative role in developing leptin resistance and obesity.
Leptin resistance, once established, diminishes counter-regulatory responses to high-calorie food, exacerbating weight gain.
These findings highlight leptin's role in obesity, particularly in environments with abundant high-calorie foods.